Study of the Safety and Efficacy of Ulipristal Acetate (UPA) Used Daily as a Contraceptive
Public ClinicalTrials.gov record NCT03296098. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Open-label, Non-comparative Study of the Safety and Contraceptive Efficacy of Continuous Daily Oral 10 mg of Ulipristal Acetate (UPA)
Study identification
- NCT ID
- NCT03296098
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Premier Research
- Other
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Ulipristal acetate Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 35 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2020
- Primary completion
- Dec 31, 2021
- Completion
- Nov 30, 2022
- Last update posted
- Nov 19, 2025
2020 – 2022
United States locations
- U.S. sites
- 18
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Essential Access | Los Angeles | California | 90010 | — |
| University of California, Davis | Sacramento | California | 95817 | — |
| University of California, San Francisco | San Francisco | California | 94110 | — |
| University of Colorado | Denver | Colorado | 80045 | — |
| University of Hawaii | Honolulu | Hawaii | 96826 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Johns Hopkins Bayview Medical Center | Baltimore | Maryland | 21224 | — |
| Planned Parenthood League of Massachusetts | Boston | Massachusetts | 02215 | — |
| New York University, School of Medicine | New York | New York | 10016 | — |
| Columbia University | New York | New York | 10032 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267 | — |
| University Hospitals of Cleveland MacDonald Women's Hospital | Cleveland | Ohio | 44106 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| University of Pennsylvania Medical Center | Philadelphia | Pennsylvania | 19104 | — |
| Univeristy of Pittsburgh School of Medicine | Pittsburgh | Pennsylvania | 15213 | — |
| Women & Infants Hospital of Rhode Island | Providence | Rhode Island | 02905 | — |
| University of Utah | Salt Lake City | Utah | 84106 | — |
| Eastern Virginia Medical School (EVMS) | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03296098, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 19, 2025 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03296098 live on ClinicalTrials.gov.